#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stiff person syndrome Hypoparathyroidism Infection in an immunocompromised host Acute leukaemia Turner's syndrome Skin cancer Niemann-Pick disease Metastases to peritoneum Haemophilia B with anti factor IX Thrombotic microangiopathy Ductal adenocarcinoma of pancreas Sarcoidosis Hepatic angiosarcoma Hyperinsulinaemic hypoglycaemia Liver transplant rejection More trials…

    Learn about Rare Diseases

    Optic glioma – Trials in Disease Alexander disease Epidermolysis bullosa – Treatment Short-bowel syndrome – Trials in Disease Toxic epidermal necrolysis Hereditary angioedema – Basic Information Wolfram syndrome – Treatment Testicular leiomyosarcoma – Basic Information Thrombotic thrombocytopenic purpura – Diagnostics Angiosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Coffee Charcoal Fezolinetant Eik1003 ARLOCABTAGENE AUTOLEUCEL Estradiol Valerate Raludotatug Deruxtecan GXV813 Vepdegestrant Rmc-6291 Binimetinib Povetacicept Somatostatin ICOTROKINRA Dextromethadone Hydrochloride Hydroxychloroquine Sulfate Insulin Lispro AZD0516 Empagliflozin Mecillinam RPTR-1-201 More therapies…

    Learn about Your Condition

    Restless legs syndrome Urethral valves Brain abscess Menopause Pemphigus Polyneuropathy Bacterial infection Dedifferentiated liposarcoma Leukaemia Herpes zoster Endometrial adenocarcinoma Iron deficiency Peritoneal sarcoma Cerebral haemorrhage Juvenile psoriatic arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Bortezomib and Temozolomide for Patients with Recurrent Grade IV Glioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant glioma
    Investigated Drugs:
    • Bortezomib
    • Temozolomide
    Norway

  • Study on the Effects of Belatacept, Ciclosporin, and Tacrolimus on Blood Vessel Health in Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Glyceryl Trinitrate
    • Belatacept
    • Ciclosporin
    France

  • Study on Improving Bone Health in Children with Cystic Fibrosis Using Cholecalciferol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Colecalciferol
    Czechia

  • Study on Changes in [18F]F-AraG Uptake After Radiotherapy in Patients with Non-Small Cell Lung Cancer, Melanoma, Breast Cancer, and Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    • Breast cancer
    • Malignant melanoma
    Investigated Drugs:
    • Nelarabine
    The Netherlands

  • Study on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Dominant or Mixed-Type Irritable Bowel Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Investigated Drugs:
    • Coffee Charcoal
    • Dry Extract From Chamomile Flower (4-6:1): Extraction Solvent: Ethanol 60% (M/M)
    • Myrrh
    Germany

  • Study on PBP1510 and Gemcitabine for Patients with Advanced Pancreatic Cancer After Previous Chemotherapy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Anti-(Pancreatic Adenocarcinoma Upregulated Factor) Igg1 Humanised Monoclonal Antibody
    Spain
Previous Page
1 … 388 389 390 391 392 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!